**Core Concept**
Acute Myeloid Leukemia (AML) is a heterogeneous group of malignancies characterized by the clonal expansion of myeloid blasts in the bone marrow. The prognosis of AML varies significantly depending on several factors, including age, performance status, and molecular characteristics of the disease.

**Why the Correct Answer is Right**
The worst prognosis in AML is associated with the presence of a specific genetic abnormality, namely, the NPM1 mutation combined with a deletion of the short arm of chromosome 5 (del(5q)). This genetic profile is often seen in AML patients who are 60 years or older and have a poor performance status. The NPM1 mutation leads to the dysregulation of cell cycle progression and apoptosis, while the del(5q) deletion results in the loss of function of the tumor suppressor genes located in this region, contributing to the aggressive behavior of the disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** AML with a normal karyotype (NK-AML) is not associated with the worst prognosis, as these patients often have a better response to chemotherapy and a higher likelihood of long-term survival.
* **Option B:** AML with a t(9;11) translocation is associated with a favorable prognosis, as this genetic abnormality is often seen in patients who respond well to chemotherapy and have a higher likelihood of achieving complete remission.
* **Option C:** AML with a t(8;21) translocation is also associated with a favorable prognosis, as this genetic abnormality is often seen in patients who have a good response to chemotherapy and a higher likelihood of long-term survival.

**Clinical Pearl / High-Yield Fact**
In AML, the presence of a specific genetic abnormality can significantly impact the prognosis and guide treatment decisions. A thorough understanding of the molecular characteristics of the disease is essential for developing effective treatment strategies and improving patient outcomes.

**Correct Answer: D.**